Dramatically boosting enrollment of minority populations in clinical trials has become a top goal of the pharmaceutical industry. One way to achieve this is by building a network of clinical trial sites focused on diversity. But stakeholders say there are many hurdles to establishing networks and note the need for partnerships to create community-based infrastructures.
“Existing clinical trial networks have been designed largely to be siloed,” Doug Peddicord, executive director of the Association of Clinical Research Organizations, said. “They’re designed to serve either the academic...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?